If you represent a sponsor/CRO, please review how to Submit Study as a Sponsor.
If you are submitting an investigator-initiated study, please review how to Submit Study as a Site.
Schulman IRB has IRB meetings every day of the business week, with special submission deadlines for Phase I and Canadian-based research.
- Please review Phase I Research to learn more about Schulman’s accelerated review timelines.
- Please review Research in Canada to learn more about review timelines.
Full Board Review Submission Deadlines
Submission deadline is one week prior to intended meeting.
Protocols that involve no greater than minimal risk to human subjects may qualify for Minimal Risk Review.
Please review Turnaround Time information to learn more about Schulman’s review timelines for specific submissions.
If you represent a research site that is part of a multi-site study, please review how to Submit Site.
If you are a sponsor/CRO representative submitting on behalf of a site, please review how to Submit Site as a Sponsor.
Most sites are reviewed daily via expedited review.
Please review Turnaround Time information to learn about common submission issues that can delay the review of your site.
To review Schulman’s expectations for investigator education and responsibilities, please reference investigator’s Responsibilities.
Use eSubmission to quickly and securely submit your materials.
Need to learn about Schulman’s current fees for service? Request Fee Schedule.
You can monitor the progress of your submission and download approval documents in real time using Schulman’s industry-leading Part-11 compliant electronic tools. Need to learn about Schulman’s electronic tools? Request WebPortal 3D Demo.
Need more help? Contact Us.